Israel Englander Larimar Therapeutics, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,018,135 shares of LRMR stock, worth $8.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,018,135

Previous 782,270 30.15%

Holding current value

$8.59 Million

Previous $5.94 Million 24.32%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.33 - $9.89 $1.49 Million - $2.33 Million	235,865 Added 30.15%	1,018,135 $7.38 Million
Q1 2024 May 15, 2024	BUY	$4.2 - $13.28 $3.29 Million - $10.4 Million	782,270 New	782,270 $5.94 Million
Q2 2023 Aug 14, 2023	SELL	$3.13 - $5.27 $979,276 - $1.65 Million	-312,868 Reduced 73.17%	114,740 $359,000
Q1 2023 May 15, 2023	BUY	$4.0 - $6.68 $884,120 - $1.48 Million	221,030 Added 107.0%	427,608 $1.94 Million
Q4 2022 Feb 14, 2023	BUY	$2.73 - $5.08 $392,402 - $730,183	143,737 Added 228.73%	206,578 $853,000
Q3 2022 Nov 14, 2022	BUY	$1.53 - $3.64 $96,146 - $228,741	62,841 New	62,841 $201,000
Q3 2021 Nov 15, 2021	SELL	$9.61 - $15.11 $2.48 Million - $3.9 Million	-257,868 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.0 - $15.2 $767,160 - $1.46 Million	-95,895 Reduced 27.11%	257,868 $2.53 Million
Q1 2021 May 17, 2021	BUY	$14.61 - $22.19 $4.63 Million - $7.03 Million	316,901 Added 859.7%	353,763 $5.17 Million
Q4 2020 Feb 16, 2021	SELL	$14.28 - $25.06 $100,302 - $176,021	-7,024 Reduced 16.01%	36,862 $789,000
Q3 2020 Nov 16, 2020	BUY	$10.5 - $17.6 $281,032 - $471,064	26,765 Added 156.33%	43,886 $666,000
Q2 2020 Aug 14, 2020	BUY	$0.72 - $16.76 $12,327 - $286,947	17,121 New	17,121 $220,000

Others Institutions Holding LRMR

# of Institutions

115

Shares Held

67.7M

Call Options Held

290K

Put Options Held

38.9K

View Full List

About Larimar Therapeutics, Inc.

Ticker LRMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,269,200
Market Cap $365M
Description
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...

More about LRMR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account